Enucleación con láser de tulio (ThuLEP) frente a resección transuretral de la próstata en solución salina (TURis): un ensayo prospectivo aleatorizado para comparar resultados intra y postoperatorios tempranos

Bozzini, Giorgio; Seveso, M.; Melegari, Sara; Francesco, O. De; Buffi, Nicolò Maria; Guazzoni, Giorgio; Provenzano, Marco; Mandressi, A.; Taverna, Gianluigi

doi:10.1016/j.acuro.2016.06.010

Cited by 31 publications

(2 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…TUERP combined with the concept of conventional open surgery and transurethral resection of the prostate, can not only completely remove the gland but can also reduce bleeding; it is less invasive to the body and has been recognized by clinical experts [29]. Although the energies used for enucleation of the prostate by urologists may be different, such as holmium laser [30], thulium laser [31], diode laser [32], or plasma kinetic energy [14,33], the principle is similar which include identification of the tissue plane between the adenoma and the surgical capsule, and anatomical enucleation of the adenoma, and this technique has the advantage of being an extravesical procedure, better controlling the bleeding and avoiding bladder incision. TUERP can reduce wound repair time, thus shortening bladder irrigation time, catheterization time, and postoperative hospital stay [12,34].…”

Section: Discussionmentioning

confidence: 99%

Multivariate Analysis of the Failure of Removal of the Urinary Catheter within 48 Hours after Transurethral Enucleation and Resection of the Prostate

Chen

Liu

2020

BioMed Research International

View full text Add to dashboard Cite

Objective. To assess the value of clinically relevant data for predicting the failure of removal of the urinary catheter within 48 hours after TUERP. Materials and Methods. We retrospectively analyzed the medical records of 357 patients who underwent TUERP between January 2015 and July 2018, all of whom stopped bladder irrigation and removed urinary catheter within 48 hours after the operation. According to whether the removal of the catheter was successful, the patients were classified into 2 groups: Group A was successful and group B was a failure. Univariate analysis was performed to determine the association between the failure of removal of the catheter and the patients’ preoperative clinical characteristics. Logistic regression analysis and receiver operating characteristic analysis (ROC) were conducted to establish the prediction model. Then the area under the curve (AUC) and the cut-off value were calculated. Results. 357 patients were divided into group A (n = 305, 85.4%) and group B (n = 52, 14.6%). The patients’ drug medication (P=0.006), history of acute urinary retention (AUR) (P≤0.001), smoke (P=0.045), IPSS (P≤0.001), IPP (P=0.006), PSA (P=0.047), residual urine volume (P≤0.001), QoL (P≤0.001), and TPV (P=0.043) were significantly different between the 2 groups. A predictive model using logistic regression was defined as follows: INDEX = 10.862–1.376 × (IPSS) − 1.185 × (QoL) − 1.062 × (drug medication) + 1.079 × (history of AUR) + 0.030 × (TPV) − 0.867 × (IPP) with area under the curve of 0.860 obtained from the ROC curve analysis. The predictive model had a cut-off value of 1.7725, and the sensitivity for predicting the failure of removal of the urethra was 74.1% and the specificity was 84.6%. Conclusion. This study demonstrated that IPSS, QoL, drug medication, history of AUR, TPV, and IPP are independent factors associated with the failure of removal of the urethral catheter within 48 hours after TUERP.

show abstract

Section: Discussionmentioning

confidence: 99%

Multivariate Analysis of the Failure of Removal of the Urinary Catheter within 48 Hours after Transurethral Enucleation and Resection of the Prostate

Chen

Liu

2020

BioMed Research International

View full text Add to dashboard Cite

show abstract

“…Several studies, systematic reviews, and meta-analysis have demonstrated the usefulness of ThuLEP in patients with BPH. [345678] There are continuous efforts in making a safe and effective tool for the management of BPH, especially in high-risk individuals, where a significant morbidity and mortality is involved in established procedures such as TURP. To the best of our knowledge, there is no literature available on the use of ThuLEP for high-risk patients.…”

Section: Introductionmentioning

confidence: 99%

Outcome of thulium laser enucleation of prostate surgery in high-risk patients with benign prostatic hyperplasia

Vartak

Raghuvanshi

2019

Urol Ann

View full text Add to dashboard Cite

Background:Benign prostatic hyperplasia (BPH) is one of the most common diseases in aging men and a significant cause of burden worldwide. Here, we report our experience of Thulium LASER enucleation of the prostate (ThuLEP) in high-risk patients with BPH.Methods:This was a prospective study conducted between July 2011 and June 2016. The study participants were patients with a confirmed diagnosis of BPH, who required surgery, and were clinically eligible for ThuLEP.Results:A total of 109 patients were included in the study. Of the total 109 patients, 82 patients had American Society of Anesthesiologists (ASA) Grade 3 and 27 had ASA Grade 4. The most common comorbidity was ischemic heart diseases (72.5%), followed by hypertension (57.8%) and diabetes mellitus (48.6%). During the procedure, a total of 11 (10.1%) patients had a fall in blood pressure requiring noradrenaline or mephentine and seven (6.4%) patients had early left ventricular failure. Sixteen (14.8%) patients had arrhythmias (benign) and seven (6.4%) patients with arrhythmias required antiarrhythmic drugs. The overall duration of surgery ranged from 55 to 70 min, laser time ranged from 25 to 35 min, hospital stay ranged from 30 to 36 h, and the mean catheter time was around 24 h. Overall, the change in hemoglobin ranged from 0.5 to 0.8 g/dL.Conclusion:Results show that ThuLEP could be a better option in high-risk patients with BPH.

show abstract

Lasers versus bipolar technology in the transurethral treatment of benign prostatic enlargement: a systematic review and meta-analysis of comparative studies

Zhou

Gurung

et al. 2019

World J Urol

View full text Add to dashboard Cite

Enucleación con láser de tulio (ThuLEP) frente a resección transuretral de la próstata en solución salina (TURis): un ensayo prospectivo aleatorizado para comparar resultados intra y postoperatorios tempranos

Cited by 31 publications

References 26 publications

Multivariate Analysis of the Failure of Removal of the Urinary Catheter within 48 Hours after Transurethral Enucleation and Resection of the Prostate

Multivariate Analysis of the Failure of Removal of the Urinary Catheter within 48 Hours after Transurethral Enucleation and Resection of the Prostate

Outcome of thulium laser enucleation of prostate surgery in high-risk patients with benign prostatic hyperplasia

Lasers versus bipolar technology in the transurethral treatment of benign prostatic enlargement: a systematic review and meta-analysis of comparative studies

Contact Info

Product

Resources

About